-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, FyP70Eda34Wc28MD4ECz2cjzv9NA43mCIbgiHCiAeSpDHTwwn1aICZ859HMhuvG1 DQtTZ3jtgP8/8jgM0Dy8LQ== 0001144204-06-014715.txt : 20060411 0001144204-06-014715.hdr.sgml : 20060411 20060411121009 ACCESSION NUMBER: 0001144204-06-014715 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20060407 ITEM INFORMATION: Departure of Directors or Principal Officers; Election of Directors; Appointment of Principal Officers FILED AS OF DATE: 20060411 DATE AS OF CHANGE: 20060411 FILER: COMPANY DATA: COMPANY CONFORMED NAME: GLYCOGENESYS INC CENTRAL INDEX KEY: 0000946661 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 330231238 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-26476 FILM NUMBER: 06752898 BUSINESS ADDRESS: STREET 1: 31 ST. JAMES AVENUE STREET 2: 8TH FLOOR CITY: BOSTON STATE: MA ZIP: 02116 BUSINESS PHONE: 6174220674 MAIL ADDRESS: STREET 1: 31 ST JAMES AVE STREET 2: 8TH FL CITY: BOSTON STATE: MA ZIP: 02116 FORMER COMPANY: FORMER CONFORMED NAME: GLYCOGENESY INC DATE OF NAME CHANGE: 20011107 FORMER COMPANY: FORMER CONFORMED NAME: SAFESCIENCE INC DATE OF NAME CHANGE: 19980401 FORMER COMPANY: FORMER CONFORMED NAME: IGG INTERNATIONAL INC DATE OF NAME CHANGE: 19950721 8-K 1 v040203_8k.htm Unassociated Document
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549


FORM 8-K


CURRENT REPORT PURSUANT
TO SECTION 13 OR 15(D) OF THE
SECURITIES EXCHANGE ACT OF 1934


Date of report (Date of earliest event reported): April 7, 2006

GlycoGenesys, Inc.
(Exact Name of Registrant as Specified in Its Charter)

Nevada 
(State or Other Jurisdiction of Incorporation)

0-26476
  
33-0231238
(Commission File Number)
  
(IRS Employer Identification No.)
 
 
    
31 St. James Avenue, Boston, Massachusetts  
 02116
(Address of Principal Executive Offices)  
(Zip Code)
     

 
(617) 422-0674 
(Registrant’s Telephone Number, Including Area Code)

Not Applicable
(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 
 
 

Item 5.02 Departure of Director and Principal Officer; Appointment of Principal Officer

On April 7, 2006, GlycoGenesys, Inc. (the “Company”) received notice from Mr. Theodore J. Host, a member of the Company’s Board of Directors, of his resignation for personal reasons effective as of April 8, 2006.

 
2
 

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
     
 
 		  
 		  
 
Dated: April 11, 2006  By:   /s/ John W. Burns
 
John W. Burns
 
Interim Chairman, Senior Vice President and Chief
Financial Officer
 
 
 
3
 
 -----END PRIVACY-ENHANCED MESSAGE-----